Article
Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jan 2018
Derks Jules L, Leblay Noémie, Thunnissen Erik, van Suylen Robert Jan, den Bakker Michael, Groen Harry J M, Smit Egbert F, Damhuis Ronald, van den Broek Esther C, Charbrier Amélie, Foll Matthieu, McKay James D, Fernandez-Cuesta Lynnette, Speel Ernst-Jan M, Dingemans Anne-Marie C
Abstract excerpt
Purpose: Previous genomic studies have identified two mutually exclusive molecular subtypes of large-cell neuroendocrine carcinoma (LCNEC): the RB1 mutated (mostly comutated with TP53) and the RB1 wild-type groups. We assessed whether these subtypes have a predictive value on chemotherapy outcome.Experimental Design: Clinical data and tumor specimens were retrospectively obtained from the Netherlands Cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
